The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.R. Artemenko

Sechenov First Moscow State Medical University (Sechenov University);
LLC Medical Center «Practical Neurology»

V.G. Abramov

Federal Siberian Research and Clinical Center

Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial

Authors:

A.R. Artemenko, V.G. Abramov

More about the authors

Views: 2275

Downloaded: 6


To cite this article:

Artemenko AR, Abramov VG. Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5):89‑99. (In Russ.)
https://doi.org/10.17116/jnevro202312305189

Recommended articles:
Modern principles of primary headaches prevention in children and adolescents. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(5):31-37
Neurological aspe­cts of connective tissue dysplasia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(7):7-11
Migraine during pregnancy and lactation. Russian Journal of Pain. 2023;(2):5-11
Effi­cacy and safety of Rela­tox for correction of platysmal bands: a clinical trial. Plastic Surgery and Aesthetic Medi­cine. 2023;(3):110-118

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.